Reckitt Benckiser appoints Marybeth Hay as a Non-Executive Director

Reckitt Benckiser

Reckitt Benckiser Group plc (LON:RKT) has announced the appointment of Marybeth Hays, a former Walmart senior executive, to the Board as a Non-Executive Director, effective 1 February 2024.

Marybeth brings more than 25 years of experience in retail, healthcare and consumer goods to the Reckitt Board. From October 2009 until February 2019, she held various roles of increasing P&L responsibility at three of the four operating divisions of Walmart, including most recently as Executive Vice President of Consumables and Health & Wellness for Walmart U.S., and as Chief Merchandising, Marketing, and Supply Chain Officer for Walmart China.  Prior to that, Marybeth served as Senior Vice President/General Merchandising Manager for two Walmart U.S. divisions and at Sam’s Club, as Merchandising Vice President at Lowe’s Companies, Inc., and held brand management roles as Vice President of Marketing at HanesBrands, Inc. 

Ms. Hays is currently a director and member of the audit committee of JOANN Stores, Inc., and serves on the board of directors for Leapfrog Brands, Affordable Care and Decowraps. Marybeth is an executive-in-residence with Kearney, and works directly with clients through her company, Hays Advising LLC. She earned both her M.B.A. and B.A. from Wake Forest University where she serves as a University Trustee and is a member of the Business School Board of Visitors.

Commenting on the appointment, Chris Sinclair, Chair of the Board said:

“I am delighted that Marybeth has agreed to join the Reckitt Benckiser Board.  She is an outstanding leader, with considerable expertise in merchandising, marketing and omnichannel gained from 25 years of general management across global retail, healthcare and consumer goods businesses. We welcome the value she will bring to the Board.”

Share on:

Latest Company News

Reckitt Benckiser appoints Deborah Waterhouse and Gavin Patterson as non-executive directors

Reckitt has appointed Deborah Waterhouse and Gavin Patterson to its Board as non-executive directors, effective from 1 July 2026.

Reckitt hosting “Focus On: Digital Science” investor seminar today

Reckitt will host its latest “Focus On” investor seminar, highlighting how its digital and R&D teams use proprietary data, predictive science and generative AI to accelerate innovation and productivity. The event begins at 15:00 BST and will be led by Chief R&D Officer Angela Naef, alongside senior finance, technology and AI leaders.

Reckitt Benckiser reports Q1 2026 growth and keeps full-year outlook unchanged

Reckitt reported Q1 2026 like-for-like net revenue growth of 0.6% for the group and 1.3% for Core Reckitt, with strong emerging markets performance partly offset by weak seasonal OTC demand, softer Europe categories and disruption in the Middle East.

Reckitt Benckiser to host investor seminar on Emerging Markets strategy

Reckitt Benckiser Group will hold its latest 'Reckitt Focus On' investor seminar, with today's session centred on Emerging Markets.

Reckitt Benckiser posts 7% Q3 revenue growth

Reckitt Benckiser delivered a 7% rise in like-for-like group revenue for Q3 2025, supported by 6.7% growth in Core Reckitt and strong momentum in Emerging Markets.

Reckitt Benckiser reports 4.2% core revenue growth and upgraded 2025 outlook

Reckitt Benckiser delivered a strong H1 2025, with Core Reckitt like‑for‑like net revenues up 4.2% and Emerging Markets growth of 12.8%. Adjusted operating profit margin improved by 110 bps to 24.6%, supporting a 5% rise in the interim dividend and an upgrade to full‑year LFL net revenue guidance above 4% for Core Reckitt.

    Search